1. Home
  2. JAKK vs SABS Comparison

JAKK vs SABS Comparison

Compare JAKK & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JAKKS Pacific Inc.

JAKK

JAKKS Pacific Inc.

HOLD

Current Price

$17.59

Market Cap

211.9M

ML Signal

HOLD

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.85

Market Cap

201.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAKK
SABS
Founded
1995
2014
Country
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.9M
201.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JAKK
SABS
Price
$17.59
$3.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$36.67
$9.80
AVG Volume (30 Days)
109.4K
397.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
5.71%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.54
N/A
P/E Ratio
$33.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.87
$1.00
52 Week High
$35.79
$6.60

Technical Indicators

Market Signals
Indicator
JAKK
SABS
Relative Strength Index (RSI) 43.09 40.87
Support Level $17.23 $3.94
Resistance Level $18.49 $4.30
Average True Range (ATR) 0.63 0.31
MACD -0.17 -0.06
Stochastic Oscillator 22.73 28.33

Price Performance

Historical Comparison
JAKK
SABS

About JAKK JAKKS Pacific Inc.

Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: